Forbes June 30, 2022
Seth Joseph

In an environment as complex as health care, it should come as no surprise that artificial intelligence (AI) technology and the machine learning market are still relatively early-on in their maturation process. Expecting the market to be farther along would be like expecting a toddler who can do single-digit addition to also do calculus; we’re just not there yet. Yet.

The authors of a recent STAT+ article entitled “A market failure is preventing efficient diffusion of health care AI software,” make a case for why AI software adoption in health care remains limited, and what the industry can/should do to advance its implementation in a clinical decision support capacity.

To correct what they consider a “market failure,” the authors “offer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Congress / White House, Govt Agencies, Provider, Technology
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft: Unlocking AI Benefits Will Require Cultural Changes for Enterprises
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.

Share This Article